Olaf Klingbeil

1.3k total citations
17 papers, 685 citations indexed

About

Olaf Klingbeil is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Olaf Klingbeil has authored 17 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Hematology. Recurrent topics in Olaf Klingbeil's work include Protein Degradation and Inhibitors (7 papers), Histone Deacetylase Inhibitors Research (4 papers) and CRISPR and Genetic Engineering (3 papers). Olaf Klingbeil is often cited by papers focused on Protein Degradation and Inhibitors (7 papers), Histone Deacetylase Inhibitors Research (4 papers) and CRISPR and Genetic Engineering (3 papers). Olaf Klingbeil collaborates with scholars based in United States, Germany and Australia. Olaf Klingbeil's co-authors include Christopher R. Vakoc, Tim D.D. Somerville, Osama E. Demerdash, Xiaoli Wu, Junwei Shi, Joseph P. Milazzo, Yuhan Huang, Mikala Egeblad, Xue‐Yan He and David L. Spector and has published in prestigious journals such as Nature, Nature Communications and Genes & Development.

In The Last Decade

Olaf Klingbeil

17 papers receiving 684 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Olaf Klingbeil United States	12	425	316	152	118	70	17	685
Ernest Medina United States	6	444 1.0×	160 0.5×	160 1.1×	80 0.7×	46 0.7×	9	607
Wenjuan Zhang China	13	502 1.2×	206 0.7×	112 0.7×	95 0.8×	31 0.4×	28	609
Jessica A. Gasser United States	8	444 1.0×	275 0.9×	112 0.7×	75 0.6×	19 0.3×	11	685
Liliya Tyutyunyk‐Massey United States	10	349 0.8×	170 0.5×	119 0.8×	105 0.9×	48 0.7×	15	623
Antonio Lucena-Cacace Spain	14	365 0.9×	261 0.8×	78 0.5×	104 0.9×	40 0.6×	23	598
Agnieszka Chęcińska Netherlands	9	314 0.7×	182 0.6×	108 0.7×	83 0.7×	33 0.5×	10	477
Julianty Frost United Kingdom	7	525 1.2×	159 0.5×	44 0.3×	217 1.8×	36 0.5×	8	731
Danrui Cui China	14	563 1.3×	220 0.7×	110 0.7×	92 0.8×	36 0.5×	27	655
Sophia X. Pfister United Kingdom	9	831 2.0×	216 0.7×	28 0.2×	139 1.2×	93 1.3×	11	959
Alan K. Ikeda United States	11	396 0.9×	120 0.4×	84 0.6×	32 0.3×	58 0.8×	20	614

Countries citing papers authored by Olaf Klingbeil

Since Specialization

Citations

This map shows the geographic impact of Olaf Klingbeil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olaf Klingbeil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olaf Klingbeil more than expected).

Fields of papers citing papers by Olaf Klingbeil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olaf Klingbeil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olaf Klingbeil. The network helps show where Olaf Klingbeil may publish in the future.

Co-authorship network of co-authors of Olaf Klingbeil

This figure shows the co-authorship network connecting the top 25 collaborators of Olaf Klingbeil. A scholar is included among the top collaborators of Olaf Klingbeil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olaf Klingbeil. Olaf Klingbeil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Skopelitis, Damianos, et al.. (2025). KLF5 enables dichotomous lineage programs in pancreatic cancer via the AAA+ ATPase coactivators RUVBL1 and RUVBL2. Nature Communications. 16(1). 9996–9996. 1 indexed citations

Klingbeil, Olaf, Damianos Skopelitis, Claudia Tonelli, et al.. (2024). MARK2/MARK3 Kinases Are Catalytic Codependencies of YAP/TAZ in Human Cancer. Cancer Discovery. 14(12). 2471–2488. 7 indexed citations

Tonelli, Claudia, Georgi N. Yordanov, Yuan Hao, et al.. (2024). A mucus production programme promotes classical pancreatic ductal adenocarcinoma. Gut. 73(6). 941–954. 14 indexed citations

Alpsoy, Aktan, Xiaoli Wu, Olaf Klingbeil, et al.. (2024). IκBζ is a dual-use coactivator of NF-κB and POU transcription factors. Molecular Cell. 84(6). 1149–1157.e7. 8 indexed citations

Klingbeil, Olaf, Bin Lü, Caizhi Wu, et al.. (2022). BRD8 maintains glioblastoma by epigenetic reprogramming of the p53 network. Nature. 613(7942). 195–202. 46 indexed citations

Parnell, Timothy J., Alex Jones, Chris Stubben, et al.. (2022). FoxA1 and FoxA2 control growth and cellular identity in NKX2-1-positive lung adenocarcinoma. Developmental Cell. 57(15). 1866–1882.e10. 22 indexed citations

Li, Ruitong, Olaf Klingbeil, Joshua M. Dempster, et al.. (2022). Comparative optimization of combinatorial CRISPR screens. Nature Communications. 13(1). 2469–2469. 20 indexed citations

Lü, Bin, Ruopeng Feng, Yu Yao, et al.. (2022). SCP4-STK35/PDIK1L complex is a dual phospho-catalytic signaling dependency in acute myeloid leukemia. Cell Reports. 38(2). 110233–110233. 4 indexed citations

Yang, Zhaolin, Xiaoli Wu, Yiliang Wei, et al.. (2021). Transcriptional Silencing of ALDH2 Confers a Dependency on Fanconi Anemia Proteins in Acute Myeloid Leukemia. Cancer Discovery. 11(9). 2300–2315. 20 indexed citations

10.

Klingbeil, Olaf, Sergey Aganezov, Peter Andrews, et al.. (2021). The human origin recognition complex is essential for pre-RC assembly, mitosis, and maintenance of nuclear structure. eLife. 10. 20 indexed citations

11.

Somerville, Tim D.D., Giulia Biffi, Juliane Daßler‐Plenker, et al.. (2020). Squamous trans-differentiation of pancreatic cancer cells promotes stromal inflammation. eLife. 9. 58 indexed citations

12.

Lü, Bin, Olaf Klingbeil, Yusuke Tarumoto, et al.. (2018). A Transcription Factor Addiction in Leukemia Imposed by the MLL Promoter Sequence. Cancer Cell. 34(6). 970–981.e8. 40 indexed citations

13.

Tarumoto, Yusuke, Bin Lu, Tim D.D. Somerville, et al.. (2018). LKB1, Salt-Inducible Kinases, and MEF2C Are Linked Dependencies in Acute Myeloid Leukemia. Molecular Cell. 69(6). 1017–1027.e6. 93 indexed citations

14.

Huang, Yuhan, Olaf Klingbeil, Xue‐Yan He, et al.. (2018). POU2F3 is a master regulator of a tuft cell-like variant of small cell lung cancer. Genes & Development. 32(13-14). 915–928. 256 indexed citations

15.

Gelato, Kathy A., Laura Schöckel, Olaf Klingbeil, et al.. (2017). Super-enhancers define a proliferative PGC-1α-expressing melanoma subgroup sensitive to BET inhibition. Oncogene. 37(4). 512–521. 33 indexed citations

16.

Klingbeil, Olaf, Ralf Lesche, Kathy A. Gelato, Bernard Haendler, & Pascale Lejeune. (2016). Inhibition of BET bromodomain-dependent XIAP and FLIP expression sensitizes KRAS-mutated NSCLC to pro-apoptotic agents. Cell Death and Disease. 7(9). e2365–e2365. 41 indexed citations

17.

Klingbeil, Olaf, Bernard Haendler, Claudia Merz, et al.. (2016). Abstract 4714: In vivo efficacy of BET inhibitor BAY 1238097 in preclinical models of melanoma and lung cancer. Cancer Research. 76(14_Supplement). 4714–4714. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact